Inhibikase Therapeutics Announces Publication Demonstrating Potential for c-Abl as a Key Therapeutic Target in Parkinson's Disease and Related Disorders
Conscious Medicine | Integrative & Functional Medicine Atlanta 6601 Sugarloaf Pkwy Ste 220, Duluth, GA 30097, United States +16782617879 https://consciousmed.co/ https://consciousmed.co/i-medicine/ https://consciousmed.co/6-key-signs-of-liver-detox-working-what-to-look-for/ https://consciousmed.co/sibo-die-off-symptoms-what-you-need-to-know/ https://consciousmed.co/how-to-treat-sibo-naturally/ Inhibikase Therapeutics Announces Publication Demonstrating Potential for c-Abl as a Key Therapeutic Target in Parkinson's Disease and Related Disorders Searching for your content... Browse News Releases In-Language News Contact Us 888-776-0942 from 8 AM - 10 PM ET Inhibikase Therapeutics Announces Publication Demonstrating Potential for c-Abl as a Key Therapeutic Target in Parkinson's Disease and Related Disorders News provided by Jan 25, 2023, 08:35 ET Share this article Share this article - Animal model studies highlight potential of the c-Abl inhibitor IkT-148009 to ...